TrialBlood2025
Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myeloma.
Dan T Vogl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it
TrialBlood2025
Dan T Vogl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.